Pure Biologics Spólka Akcyjna

Pure Biologics Spólka Akcyjnaverified

PUR.WA

Price:

$4.162

Market Cap:

$33.30M

Pure Biologics Spólka Akcyjna, a biopharmaceutical company, engages in the research and development of biological drugs and non-systematic therapies in the field of immuno-oncology, autoimmunology, and rare diseases. It is involved in the production, purification, analysis, and characterization of antibodies and aptamers; and design, development, and validation of assays, as well as conducts research on technology platforms for selecting active molecules. The company offers PureApta, a modular platform for in vitro selection of modified aptamers for therapeutic and diagnostic use. It also engages in the development of non-systemic therapies for use in treating patients suffering from neurolo...[Read more]

Industry

Biotechnology

IPO Date

2018-12-01

Stock Exchange

WSE

Ticker

PUR.WA

The Enterprise Value as of December 2025 (TTM) for Pure Biologics Spólka Akcyjna (PUR.WA) is 47.49M

According to Pure Biologics Spólka Akcyjna’s latest financial reports and current stock price. The company's current Enterprise Value is 47.49M. This represents a change of -39.08% compared to the average of 77.95M of the last 4 quarters.

Pure Biologics Spólka Akcyjna (PUR.WA) Historical Enterprise Value (quarterly & annually)

How has PUR.WA Enterprise Value performed in the past?

The mean historical Enterprise Value of Pure Biologics Spólka Akcyjna over the last ten years is 71.67M. The current 47.49M Enterprise Value has changed 6.53% with respect to the historical average. Over the past ten years (40 quarters), PUR.WA's Enterprise Value was at its highest in in the December 2020 quarter at 232.50M. The Enterprise Value was at its lowest in in the September 2017 quarter at 0.

Quarterly (TTM)
Annual

Average

71.67M

Median

49.65M

Minimum

12.06M

Maximum

180.47M

Pure Biologics Spólka Akcyjna (PUR.WA) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Pure Biologics Spólka Akcyjna Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 315.41%

Maximum Annual Enterprise Value = 180.47M

Minimum Annual Increase = -69.55%

Minimum Annual Enterprise Value = 12.06M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2024102.08M105.60%
202349.65M-3.95%
202251.69M-69.55%
2021169.74M-5.95%
2020180.47M315.41%
201943.44M83.32%
201823.70M94.73%
201712.17M0.89%

Pure Biologics Spólka Akcyjna (PUR.WA) Average Enterprise Value

How has PUR.WA Enterprise Value performed in the past?

The current Enterprise Value of Pure Biologics Spólka Akcyjna (PUR.WA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

67.80M

5-year avg

110.72M

10-year avg

71.67M

Pure Biologics Spólka Akcyjna (PUR.WA) Enterprise Value vs. Peers

How is PUR.WA’s Enterprise Value compared to its peers?

Pure Biologics Spólka Akcyjna’s Enterprise Value is less than Urteste S.A. (51.31M), greater than Pharmena S.A. (33.96M), less than Airway Medix S.A. (48.47M), less than BioMaxima S.A. (64.30M), less than NanoGroup S.A. (89.14M), less than Genomtec S.A. (54.95M), less than Poltreg S.A. (88.22M), less than Mabion S.A. (109.49M), greater than Adiuvo Investments S.A. (33.70M), less than Molecure S.A. (116.23M),

CompanyEnterprise ValueMarket cap
51.31M$51.73M
33.96M$33.97M
48.47M$36.35M
64.30M$48.43M
89.14M$90.06M
54.95M$66.21M
88.22M$111.46M
109.49M$129.62M
33.70M$8.56M
116.23M$150.20M

Build a custom stock screener for Pure Biologics Spólka Akcyjna (PUR.WA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Pure Biologics Spólka Akcyjna using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Pure Biologics Spólka Akcyjna (PUR.WA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Pure Biologics Spólka Akcyjna or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Pure Biologics Spólka Akcyjna's Enterprise Value?

What is the highest Enterprise Value for Pure Biologics Spólka Akcyjna (PUR.WA)?

What is the 3-year average Enterprise Value for Pure Biologics Spólka Akcyjna (PUR.WA)?

What is the 5-year average Enterprise Value for Pure Biologics Spólka Akcyjna (PUR.WA)?

How does the current Enterprise Value for Pure Biologics Spólka Akcyjna (PUR.WA) compare to its historical average?